TERNS PHARMACEUTICALS INC (TERN) Stock Earnings & Estimates
USA - NASDAQ:TERN - US8808811074 - Common Stock
18.19 USD
+0.76 (+4.36%)
18.1 USD
-0.09 (-0.49%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1M | -100.00% | 16.32M | 19.082M 16.92% | 139.18M 629.38% | 215.41M 54.77% | 424.72M 97.17% | ||||||||
| EBITDA YoY % growth | -70M -280.64% | -36.64M 47.66% | -49.35M -34.69% | -64.25M -24.72% | -104.478M -65.19% | -105.06M 0.69% | -115.078M -13.97% | -128.696M -11.83% | -144.289M -12.12% | -118.116M 18.14% | -95.778M 18.91% | 125.97M 231.52% | 166.97M 32.55% | 514.39M 208.07% | |
| EBIT YoY % growth | -70.2M -280.28% | -37.03M 47.25% | -49.86M -34.65% | -64.802M -24.41% | -135.246M -65.34% | -105.442M 0.67% | -117.86M -15.70% | -139.733M -18.56% | -157.57M -12.77% | -149.009M 5.43% | -128.027M 14.08% | -19.276M 84.94% | 48.872M 353.53% | 271.58M 455.70% | |
| Operating Margin | N/A | N/A | -4,986.00% | N/A | N/A | N/A | N/A | N/A | N/A | -913.05% | -670.93% | -13.85% | 22.69% | 63.94% | |
| EPS YoY % growth | N/A | N/A | -2.34 28.53% | -1.92 21.79% | -1.36 30.60% | -1.23 11.02% | -1.15 -1.68% | -1.37 -19.03% | -1.59 -16.07% | -1.40 11.65% | -0.34 76.00% | 0.45 233.33% | 0.59 31.82% | 1.61 172.41% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 -9.19% | -0.31 -31.11% | -0.32 -22.79% | -0.33 -27.89% | -0.36 -16.76% | -0.38 -21.34% | -0.35 -8.63% | -0.35 -4.29% | -0.37 -2.86% | -0.39 -1.51% | -0.40 -14.71% | -0.40 -14.71% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | ||||||
| EBITDA Q2Q % growth | -29.348M -20.68% | -30.025M -19.84% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -30.958M -23.83% | -33.146M -27.74% | -33.727M -22.97% | -36.292M -32.54% | -46.308M -49.58% | -52.122M -57.25% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.26 16.13% | -0.30 | 0.04 | 12.10% |
| Q1 2025 Q2Q % growth | -0.26 13.33% | -0.29 | 0.03 | 8.96% |
| Q4 2024 Q2Q % growth | -0.24 17.24% | -0.32 | 0.08 | 24.07% |
| Q3 2024 Q2Q % growth | -0.28 33.33% | -0.33 | 0.05 | 14.33% |
| Q2 2024 Q2Q % growth | -0.31 -24.00% | -0.35 | 0.04 | 10.61% |
| Q1 2024 Q2Q % growth | -0.30 3.23% | -0.34 | 0.04 | 12.85% |
| Q4 2023 Q2Q % growth | -0.29 | -0.30 | 0.01 | 2.71% |
| Q3 2023 Q2Q % growth | -0.42 4.55% | -0.31 | -0.11 | -34.76% |
| Q2 2023 Q2Q % growth | -0.25 54.55% | -0.35 | 0.10 | 27.68% |
| Q1 2023 Q2Q % growth | -0.31 43.64% | -0.27 | -0.04 | -13.53% |
| Q4 2022 Q2Q % growth | -0.29 48.21% | -0.44 | 0.15 | 33.88% |
| Q3 2022 Q2Q % growth | -0.44 6.38% | -0.53 | 0.09 | 17.04% |
| Q2 2022 Q2Q % growth | -0.55 -27.91% | -0.61 | 0.06 | 9.12% |
| Q1 2022 Q2Q % growth | -0.55 37.50% | -0.66 | 0.11 | 16.18% |
| Q4 2021 Q2Q % growth | -0.56 98.19% | -0.64 | 0.08 | 12.39% |
| Q3 2021 Q2Q % growth | -0.47 | -0.62 | 0.15 | 23.63% |
| Q2 2021 Q2Q % growth | -0.43 | -0.72 | 0.29 | 40.62% |
| Q1 2021 Q2Q % growth | -0.88 | -0.79 | -0.09 | -11.56% |
| Q4 2020 Q2Q % growth | -30.94 | -0.93 | -30.01 | -3,233.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.61% | 1.03% | -1.47% | 4.1% |
| Revenue | N/A | N/A | N/A | N/A |